1. Home
  2. BRC vs AMRX Comparison

BRC vs AMRX Comparison

Compare BRC & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Brady Corporation

BRC

Brady Corporation

HOLD

Current Price

$77.32

Market Cap

3.7B

ML Signal

HOLD

Logo Amneal Pharmaceuticals Inc.

AMRX

Amneal Pharmaceuticals Inc.

HOLD

Current Price

$11.98

Market Cap

3.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BRC
AMRX
Founded
1914
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Miscellaneous manufacturing industries
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.7B
3.8B
IPO Year
1984
N/A

Fundamental Metrics

Financial Performance
Metric
BRC
AMRX
Price
$77.32
$11.98
Analyst Decision
Buy
Analyst Count
0
4
Target Price
N/A
$13.25
AVG Volume (30 Days)
224.3K
1.7M
Earning Date
11-17-2025
10-30-2025
Dividend Yield
1.26%
N/A
EPS Growth
0.61
N/A
EPS
4.08
0.02
Revenue
$1,541,827,000.00
$2,934,959,000.00
Revenue This Year
$6.76
$9.99
Revenue Next Year
$3.84
$6.67
P/E Ratio
$19.00
$745.76
Revenue Growth
11.21
9.50
52 Week Low
$62.70
$6.69
52 Week High
$84.03
$12.68

Technical Indicators

Market Signals
Indicator
BRC
AMRX
Relative Strength Index (RSI) 50.52 55.77
Support Level $77.33 $11.83
Resistance Level $79.36 $12.25
Average True Range (ATR) 1.90 0.33
MACD -0.13 -0.08
Stochastic Oscillator 41.54 44.31

Price Performance

Historical Comparison
BRC
AMRX

About BRC Brady Corporation

Brady Corp provides identification solutions and workplace safety products. The company offers identification and healthcare products that are sold under the Brady brand to maintenance, repair, and operations as well as original equipment manufacturing customers. Products include safety signs and labeling systems, material identification systems, wire identification, patient identification, and people identification. Brady also provides workplace safety and compliance products such as safety and compliance signs, asset tracking labels, and first-aid products. The company is organized and managed on a geographic basis with two reportable segments: Americas & Asia which derives maximum revenue, and Europe & Australia.

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

Share on Social Networks: